AI agents in Pharmaceutical Preparations
17 companies in SIC 2834 (Pharmaceutical Preparations) have AI-agent language in SEC filings since 2025-01-01; 7 have at least one model-judged first-party deployment.
| Company | Stage | Functions | Mkt cap | Filings | Latest |
|---|---|---|---|---|---|
| Lantern Pharma Inc.LTRN | Scaling | Healthcare & clinical, HR & recruiting, IT & security ops, Software development | $9M | 8 | 2026-09-24 |
| Schrodinger, Inc.SDGR | Scaling | Finance & accounting, Healthcare & clinical, IT & security ops, Legal & compliance, Operations & supply chain | $1.7B | 3 | 2026-08-05 |
| CDT Equity Inc.CDT | Scaling | IT & security ops | $0M | 6 | 2026-09-08 |
| Shuttle Pharmaceuticals Holdings, Inc.SHPH | Scaling | Healthcare & clinical, IT & security ops | $25M | 7 | 2026-09-24 |
| AIxCrypto Holdings, Inc.QLGN | Deployed | Healthcare & clinical, IT & security ops, Operations & supply chain, Sales & marketing | — | 11 | 2026-08-18 |
| Olema Pharmaceuticals, Inc.OLMA | Deployed | Legal & compliance | $569M | 3 | 2026-08-10 |
| ARVINAS, INC.ARVN | Deployed | Healthcare & clinical, IT & security ops, Legal & compliance | $455M | 1 | 2026-08-04 |
| Seres Therapeutics, Inc.MCRB | Piloting | Healthcare & clinical | $25M | 2 | 2026-07-08 |
| KALA BIO, Inc.KALA | Piloting | Healthcare & clinical, IT & security ops | $4M | 5 | 2026-08-19 |
| Silo Pharma, Inc.SILO | Piloting | Healthcare & clinical, Operations & supply chain | $2M | 3 | 2026-08-13 |
| Merck & Co., Inc.MRK | Mentions only | — | $362.3B | 1 | 2026-04-30 |
| BeOne Medicines Ltd.ONC | Mentions only | Healthcare & clinical, IT & security ops, Legal & compliance, Operations & supply chain | $42.0B | 2 | 2026-08-05 |
| Arcturus Therapeutics Holdings Inc.ARCT | Mentions only | IT & security ops, Legal & compliance | $299M | 1 | 2026-03-03 |
| Semnur Pharmaceuticals, Inc.SMNR | Mentions only | Legal & compliance, Sales & marketing | $119M | 3 | 2026-08-10 |
| Onconetix, Inc.ONCO | Mentions only | IT & security ops | $3M | 1 | 2026-02-12 |
| Lyell Immunopharma, Inc.LYEL | Risk factors only | Legal & compliance | $200M | 4 | 2026-08-06 |
| Lite Strategy, Inc.LITS | Risk factors only | — | $36M | 1 | 2026-09-28 |